PharmaShots Weekly Snapshot (November 04-08, 2019)
1. Triumvira’s TAC01-CD19 Receives FDA’s Fast Track Designation for R/R Diffuse Large B-Cell Lymphoma Published: Nov 07, 2019 | Tags: Triumvira, TAC01-CD19, Receives, FDA,
[Read More...]
Vela Diagnostics
Vela Diagnostics’ Sentosa SQ HIV-1 Genotyping Assay Receives the US FDA’s DE Novo Authorization for Detection of HIV-1 Genomic Drug Resistance Mutations (DRMs)
Shots: The novel HIV-1 Genotyping assay uses the plasma of patients infected with HIV-1 to detect HIV-1 Group M DRMs in the protease,
[Read More...]